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Abstract 
Background: The effectiveness of screening in colorectal cancer prevention depends on 
sustained participation rates. The objective of this study was to explore factors related to the 
longitudinal adherence of screening behavior in the context of a biennial population-based 
cancer screening program. 
Methods: Eight focus groups were conducted with individuals who were invited two or three 
consecutive times to a population-based colorectal cancer screening program using a fecal 
occult blood test and who agreed to participate in the program at least once (n=45). The criteria 
used to select the study members included adherence to fecal occult blood test maintenance, 
factors regarding their initial participation in the colorectal cancer screening, sex and contextual 
educational level. 
Results: The participants expressed a high level of satisfaction with the program; however, they 
showed a low level of understanding with respect to cancer screening. Consulting a general 
practitioner was cited by all participants as an important factor that mediated their final decision 
or influenced their behavior as a whole with regard to the program. Fear played a different role 
in the screening behavior for regular and irregular adherent participants. In the adherent 
participants, fear facilitated their continued participation in the screening program, whereas for 
the irregular participants, fear led them to avoid or refuse further screening. 
Having a close person diagnosed with colorectal cancer was a facilitator for the regular 
adherent participants. The irregular adherent participants showed some relaxation with respect 
to screening after a negative result and considered that further screening was no longer 
necessary. 
Conclusion: Considering the importance of primary healthcare professionals in the decision 
regarding sustained participation, it is important to better engage them with cancer screening 
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programs, as well as improve the communication channels to provide accurate and balanced 
information for both health professionals and individuals. 
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Factors related to longitudinal adherence in colorectal cancer screening: qualitative 
research findings 
 
Introduction 
Colorectal cancer (CRC) is one of the most common tumors in the population and the third 
leading cause of cancer death among both women and men in developed countries (Ferlay et 
al., 2013). 
Screening for CRC provides a simple and effective public health intervention to prevent and 
minimize the impact of CRC on the community. Convincing evidence supports a guaiac fecal 
occult blood test (gFOBT), sigmoidoscopy and colonoscopy as screening tools (Atkin et al., 
2010; Brenner et al., 2014a; Brenner et al., 2014b; Hardcastle et al., 1996; Hewitson et al., 
2008; Krönborg et al., 1996; Mandel et al., 2000; Schoen et al., 2012; Segnan et al., 2011). 
However, a debate exists regarding which approach to implement. Benefits should be weighed 
against the costs, discomfort, complication rates, capacities needed, and potential differences in 
compliance. The Council of the European Union recommended the implementation of 
population-based screening programs for CRC using the gFOBT every 2 years in men and 
women between the ages of 50 and 74 years (CEC, 2003). Consequently, many countries, such 
as the United Kingdom, Spain, Finland, and France, have implemented population-based 
screening programs based on the gFOBT (Peris et al., 2007; von Wagner et al., 2011; Leuraud 
et al., 2013), whereas in regions of Italy, screening programs based on a fecal immunochemical 
test (FIT) have been adopted (Grazzini et al., 2004; Crotta et al., 2012). In several studies 
conducted in average-risk populations, a higher detection rate of advanced adenomas and CRC 
of the FIT, as well as a higher uptake rate have been identified compared with gFOBT 
screening (van Rossum et al., 2008; Hol et al., 2010; García et al., 2011; Tinmouth et al, 2015). 
Consequently, the FIT is becoming a widely favored option for replacing the gFOBT. 
Decreases in mortality rates for cancer in the population as a whole predominately depend on 
the percentage of participation in the screening programs (Parkin et al., 2008). The European 
Commission considers 45% an acceptable participation rate, whereas it recommends a 
participation rate of 65-70% (von Karsa et al., 2008). Most European programs achieve this 
accepted minimum; however, according to the European Commission, only Finland and the 
Netherlands reach the recommended rates (Ponti et al., 2017). Reductions in mortality may only 
be attained if uptake is adequate and sustained over time (Weller et al., 2009). Although high 
rates of adherence to repeat gFOBT screening have been reported in randomized trials (38-
60%), longitudinal adherence to CRC screening in the population is expected to be substantially 
lower. A high level of ongoing and timely participation in screening is necessary to determine its 
effectiveness in reducing mortality from CRC (Calazel-Benque et al., 2011). 
Screening invitations are typically repeated every 2 years, and the effectiveness of the gFOBT 
or FIT screening program is highly dependent on participation in multiple rounds, i.e., the 
longitudinal adherence. Ideally, eligible invitees accept the invitation to be screened at every 
screening round (Gellad et al, 2011; Steele et al., 2014; van der Vlugt et al., 2017). 
A high rate of consistent participation increases the program sensitivity of CRC screening 
(Winawer et al., 1993; Nishihara et al., 2013; van der Vlugt et al., 2017). However, the success 
of a biennial screening program may be overestimated if there is a low willingness to participate 
in multiple rounds. To our knowledge, limited studies have examined longitudinal adherence to 
the FOBT over several years (Denis et al., 2015; Gellad et al, 2011; Kapidzic et al., 2014; Myers 
et al., 1993; O’ Malley et al., 2002; Milà et al., 2012; Steele et al, 2014; van der Vlugt M, 2017). 
Most studies have focused on one-time screening rather than longitudinal adherence. Myers et 
al. evaluated compliance rates with the gFOBT over 2 years among adult members of a health 
maintenance organization. They determined that only 23% of subjects completed two rounds of 
screening, with predictors of adherence including initial adherence and an age >65 years 
(Myers et al., 1993). O’Malley et al. used a targeted household telephone survey to evaluate 
adherence to an annual gFOBT in women over a 2-year period. They determined that only 29% 
of women completed two gFOBTs during the study period (O’Malley et al., 2002). Gellad et al. 
concluded that the proportion of individuals who received an adequate gFOBT screening was 
14.1% for men and 13.7% for women over a 5-year period (Gellad et al., 2011). 
Therefore, these results show that longitudinal adherence is an important aspect of colorectal 
cancer screening, as participation is currently between 40-60%; thus, the loss of this percentage 
of participating individuals is an important aspect to consider. Moreover, there is limited 
knowledge regarding the determinants of longitudinal adherence to fecal testing in population-
based CRC screening programs. 
The identification of potential determinants of inconsistent participation could aid in targeting the 
information to specific groups. Several studies and systematic reviews have been conducted to 
analyze reasons for participation in colorectal cancer screening (Honein-AbouHaiar et al., 2016; 
Khalid-de Bakker et al., 2011; von Euler-Chelpin et al., 2010); however, limited studies have 
assessed the reasons for longitudinal adherence. These limited studies indicate the factors that 
determine initial participation are different from the factors that determine longitudinal 
adherence to cancer screening (Lo et al., 2014; Lo et al., 2015; Palmer et al., 2014). 
To develop interventions to encourage routine screening for colorectal cancer, it may be 
important to understand the differences among individuals who do and do not undergo repeat 
screening. Thus, the objective of this study was to explore factors related to the longitudinal 
adherence of screening behavior in the context of a biennial population-based CRC screening 
program using the FOBT in Catalonia, Spain.  
Methods 
We conducted a qualitative study using focus groups (FGs) that consisted of men and women 
between the ages of 50 and 69 years who had been invited to participate in the CRC screening 
program. FGs were chosen as the primary method of data collection because of their emphasis 
on participant interactions and potential to encourage greater candor, which make them 
particularly well-suited to investigate decision-making processes. 
Sample selection 
Our sample was derived from the population that had been invited to participant in CRC 
screening in 2010 in an industrial city of approximately 260,288 inhabitants, where the 
screening program was initially launched. From this population, we selected individuals who 
were invited at least twice, and the FGs were conducted after one year.  
The screening program comprised a free, public, biennial, population-based screening program 
for colorectal cancer using the fecal occult blood test, which was provided free of charge to men 
and women aged 50 to 69 years. In the first four rounds, the guaiac test was used. An 
immunological test was subsequently applied. Eligible subjects were mailed a personal 
invitation letter, which was signed by the individual in charge of the screening program. Subjects 
with negative test results were informed by mail. All screened individuals with a positive FOBT 
were contacted by phone to provide information regarding the screening result and advise them 
that they would be referred for a colonoscopy examination. A more detailed description of the 
screening procedure is provided elsewhere (Peris et al., 2007). 
Based on the available data from the CRC screening program, we devised a purposeful 
sampling strategy using a combination of intensity and maximum variation sampling (Patton, 
2002) based on three criteria: ‘prior screening behavior’, ‘sex’ and ‘educational level’. 
The ‘prior screening behavior’ criterion was defined as colorectal cancer screening adherence in 
at least two consecutive screening rounds. We classified individuals as ‘regular adherent 
participants’ if they participated as many times as invited and as ‘irregular adherent participants’ 
if they participated fewer times than invited. 
The ‘educational level’ criterion was defined using aggregate data, obtained from the census 
data (L’Hospitalet de Llobregat City Council, 2010), given that we did not have information 
regarding individual educational levels. Thus, we selected individuals who lived in a 
neighborhood (Area 1) with a poor educational level (26.64% of individuals with a level lower 
than primary studies) and individuals from a neighborhood (Area 2) with a better educational 
level (18.73% of individuals with a level lower than primary studies). 
Data collection 
The composition of the FGs was stratified by ‘prior screening behavior’, ‘educational level’ and 
‘sex’ to ensure homogeneity in terms of the background and enable candid discussions 
regarding colorectal cancer screening procedures. In addition, we considered factors related to 
their initial participation in the colorectal cancer screening, such as the ease of recruitment 
(acceptance to participate immediately after receiving the screening invitation or six weeks after 
issue of the first invitation), the number of kits used and the FOBT result (negative or 
inconclusive FOBT) to ensure heterogeneity in terms of attitudes and experiences. 
Eight FGs were conducted with 45 participants who had been invited two or three times to a 
population-based colorectal cancer screening program using the FOBT and who agreed to 
participate in the program at least once (Table 1). The sample size was determined by data 
saturation using concurrent data analysis. Prior to starting the FGs, the study team developed a 
topic guide that covered the key objectives of the study (Table 2). Written informed consent was 
obtained from all individuals who attended a focus group session. The study protocol was 
approved by the Clinical Research Ethics Committee of Bellvitge University Hospital (230/05). 
After each FG was completed, the facilitators participated in a structured, self-administered 
debriefing session and completed their field notes. All FGs were audio or video recorded and 
transcribed verbatim. The transcripts were anonymized and reviewed by two members of the 
research team for accuracy. The FGs were conducted and transcribed in the native language of 
the participants (Catalan and Spanish). Selected data excerpts were then professionally 
translated into English for reporting. 
Data analysis 
Transcripts and field notes were subjected to thematic analysis (Braun & Clarke, 2006) with the 
assistance of ATLAS.ti software for data management (Muhr, 2004). Debriefing discussions and 
field notes served as the basis to refine the initial coding, which was subsequently discussed 
and refined by the research team, resulting in an initial set of 18 descriptive themes (Table 3). 
We subsequently generated analytical themes by further interrogating the data set drawing on 
the constant comparative method (Glaser, 1965). Codes and emerging themes were then 
discussed, revised, refined and agreed upon by the research team through critique and  
consensus. As a result, three overarching analytical themes were established: (1) common 
factors underpinning the screening experiences and decisions of regular and irregular adherent 
participants; (2) common factors interpreted in opposing ways by regular and irregular adherent 
participants; and (3) differential factors across regular and irregular adherent participants. 
Results 
Common factors underpinning the screening experiences and decisions of regular and 
irregular adherent participants 
These factors were identified in both the regular and irregular adherent participants when 
explaining their views regarding the program and their screening experience. 
Perceived benefit of prevention 
One key overarching finding was that the system of beliefs concerning generic preventive health 
issues of both the regular and irregular adherent participants did not appear to significantly differ 
(Table 4, quotes 1-3). 
 With respect to the specific convergences between the regular and irregular adherent 
participants in relation to their screening experience and decisions, they were particularly 
significant because they were expected to play a decisive role in the participants’ decision-
making process during the screening period. However, this expectation was not supported 
because they were shared by the regular and irregular adherent participants. These factors 
were as follows: a lack of comprehension, a lack of media information and a high level of 
satisfaction with the program. 
Lack of comprehension  
The lack of comprehension referred to all manifestations of incomprehension that were more or 
less explicitly expressed by the participants, which mainly comprised difficulties in 
comprehension concerning the process to be followed to participate in the program, the periods 
established between rounds, the age limits established by the program and, in general, the 
rationale underlying a population-based screening program or the preventive health 
actions/policies that tend to collide with everyday life views (Table 4, quotes 4-6). 
Initially, the possibility of incomprehension was valued as a handicap or a barrier to 
participation; however, these manifestations of incomprehension were identified in both the 
regular and irregular adherent participants. Therefore, it cannot be concluded that they 
influenced adherence to the program. 
Lack of information regarding CRC in the media 
The lack of information regarding CRC in the media was a recurrent complaint that both the 
regular and irregular adherent participants highlighted at various points during the FG sessions. 
They tended to refer mainly to the information provided on TV and the written press regarding 
CRC. They also identified differential treatment by the media, for example, in relation to other 
cancers, such as breast or lung cancer, or in relation to other diseases that tend to be 
considered thematically relevant to the public in general (Table 4, quotes 7-9).  
Satisfaction with the program 
A high level of satisfaction with the program is another factor that was identified in the regular 
and irregular adherent participants. This satisfaction was expressed through three main 
considerations: 
1. The elements of comfort provided by the program procedure, which enabled them to protect 
their health and act preventively without going to a hospital or consultation (Table 4, quote 
10). 
2. The clarity by which the instructions are given to the patient during every step of the 
screening process (Table 4, quote 11). 
3. The health benefit that this type of service introduces to the population in general and to 
them in particular (Table 4, quote 12). 
Therefore, the views and positions regarding preventive health activities in general and the 
screening program in particular were convergent and followed similar patterns. However, the 
narratives and arguments of the regular and irregular adherent participants also indicated key 
factors that helped explain the differences in their actual decisions regarding CRC screening. 
These factors were divided into two types: (a) common factors interpreted in opposing ways, 
which were shared between the regular and irregular adherent participants but interpreted in 
opposing ways in each case’s decision-making process; and (b) differential factors, which were 
identified exclusively in the adherent or non-adherent participants. 
Common factors interpreted in opposing ways by regular and irregular adherent 
participants 
These factors were identified in both the regular and irregular adherent participants as important 
factors that played a significant role in the decisions of the participants regarding the screening. 
The particularity of these factors is the fact that they were interpreted in opposing ways by the 
regular and irregular adherent participants: the same factors opposed implications. These two 
factors were fear and consulting a general practitioner. 
The role of fear in participants’ decision-making 
Fear was recursively based on the regular and irregular adherent participants’ views and 
explanations. These fears were related to the illness, colorectal cancer, and several questions 
that typically surround it: fear of suffering, fear of the way of life of sick individuals, and other 
questions. Nevertheless, these fears were interpreted in two clearly opposed ways by the 
regular adherent and irregular adherent participants in terms of the decisions they made during 
the screening period. 
In contrast, the regular adherent participants identified this factor to explain and argue why they 
decided to participate every time they were invited (Table 4, quotes 13-14). The irregular 
adherent participants also used this factor to explain and argue why they sometimes decided to 
stop participating (Table 4, quotes 15-16). Therefore, the possibility of being in fear acted as an 
encouragement to participate in every round for the regular adherent participants, whereas for 
the irregular adherent participants, fear was sufficiently paralyzing to modify their screening 
behavior over time. 
Consulting a GP as part of the decision-making process  
Consulting a general practitioner was a common practice between the regular and irregular 
adherent participants that was conducted after receiving the invitation to participate and before 
making the decision to participate and maintain this decision throughout the screening period. 
This factor was cited by all participants as an important factor that mediated their final decision 
or influenced their behavior as a whole with respect to the program. However, this influence was 
again exerted in two opposing ways for the regular and irregular adherent participants. 
The regular adherent participants experienced an action of reinforcement (in the form of 
additional explanations, showing support, making the patient aware of the importance of the 
preventive action, and other factors) as feedback from the GPs when they told them about their 
invitation to the screening program (Table 4, quotes 17-18). The irregular adherent participants 
experienced a lack of reinforcement (not sufficient importance attached by the GP, a lack of 
needed explanations, and other factors) as feedback from the GP, which they tended to link to 
incorrect medical attention (Table 4, quotes 19-20). 
Differential factors across regular and irregular adherent participants 
These factors were identified solely in the regular or irregular adherent participants. Therefore, 
they appeared to be key factors in the decisions made during the screening period. 
Regular adherent participants: having a close person diagnosed with CRC 
Having a close person diagnosed with CRC was a distinct element of the regular adherent 
participants’ experiences (Table 4, quotes 21-24). The effects of both the closeness of the 
experience and the level of affectation were of a relative nature, which indicates that the 
experience could refer to nuclear or extended relatives, as well as friends, work mates or 
neighbors. Furthermore, the participants’ experiences could refer to fatal cases of CRC 
affectation or a wide range of cases that were perceived as difficult by the participants. 
Although this factor was significant in all adherent groups, it was not used by the participants to 
attribute relevancy to their arguments when explaining their adherent behavior. 
Irregular adherent participants: prioritization issues and being relaxed about screening after a 
negative result 
A distinct factor that characterized the experiences of the irregular adherent participants was the 
prioritization of everyday tasks and activities over the actions needed to participate in the 
screening program. 
As a result, all actions with regard to program participation (e.g., answer the letter, ask for the 
FOBT kit, collect the samples, and send them back) were not regarded as preferential in the 
context of the participants’ everyday life. Therefore, these actions were postponed until or 
beyond the deadline established by the program to participate in each round (Table 4, quotes 
25-26). 
A key argument to explain these prioritization issues was the emergence of a relaxation effect 
after a negative screening result. The irregular adherent participants highlighted that after they 
obtained a negative result in a previous round, they tended to feel safe and reassured, thus 
assuming that 'everything is OK' with regard to their health as a two-year period was not viewed 
as sufficient time for anything to have changed in this respect (Table 4, quotes 27-28). 
Discussion 
Our study identified factors related to the longitudinal adherence of screening behavior 
for colorectal cancer in Catalonia, Spain. Facilitating factors and barrier factors were identified 
by irregular and regular participants in a CRC screening program through FGs. The factors 
identified by this study include a lack of comprehension, fear of the consequences of screening, 
inconsistent or inadequate support for screening from providers and the media, and a relaxation 
effect after a negative result in the FOBT, which coincided with the results of other studies that 
analyzed facilitators and barriers for participation in colorectal cancer screening using qualitative 
methodology and the FOBT, colonoscopy or flexible sigmoidoscopy as screening methods 
(Honein-AbouHaidar et al., 2016; Jones et al., 2010; Wools et al., 2016). 
Fear: The presence of fear as an important influence has been documented in other 
screening studies (Amonkar et al., 1999). Cancer fear may be a facilitator or a deterrent, 
depending on the specific aspect of the fear. The presence of cancer as the greatest health fear 
or substantially worrying about cancer facilitated intentions to attend, whereas uncomfortable 
thoughts of cancer did not affect the intention and were a deterrent to actual participation 
(Vrinten et al., 2015). Consistent with the results of other studies, cancer worry facilitated 
screening by enhancing the intention to attend, which may be motivated by a desire for 
reassurance, whereas a more visceral negative response to thinking about cancer acted as a 
deterrent in the action stage (Clemow et al., 2000; Jandorf et al., 2010; Wong et al., 2013). This 
deterrent effect is referred to as the “ostrich effect”, in which an individual prefers not to obtain 
information regarding her state of affairs because of the fear that she may receive bad news, 
despite the prospect of making better decisions based on this information (Panidi, 2014). 
Lack of comprehension: It has been observed a lack of comprehension of cancer 
screening in both regular and irregular adherence participants, but it could be minimized by 
primary healthcare professionals. 
Inconsistent or inadequate support from providers: Consistent with other screening 
tests, the population clearly expected to receive information regarding colorectal screening from 
their physicians. Our findings reinforce the importance of shared decision-making between 
providers and consumers. Decision aids to support doctors in their discussions with patients 
may be valuable, given the need to balance potential risks and benefits, as well as the different 
perspectives on test quality and acceptability that were expressed (Goel et al., 2004). Primary 
healthcare professionals can facilitate informed choices by patients who participate in CRC 
screening, and this role requires health care to have access to relevant, accurate and complete 
information. 
Considering the lack of comprehension and the importance of primary healthcare professional 
in the decision on sustained participation, it is important to better engaged them with cancer 
screening programs, and also improve the communication channels. Possible methods for 
facilitating communication could include continuous briefings, regular message reminders or 
educational websites. Screening information is currently given to the individuals by a brochure 
sent by mail. This communication channel is certainly quick and economical but does not 
guarantee the individuals' good understanding of the benefits and risks of screening. It would be 
preferable that primary health care professional to have a private interview and to discuss such 
documents when their patients come in for a medical consultation. General practitioner could 
increase their involvement in CRC screening if they were more associated with patient 
information at different stages of screening. Their privileged mode of communication remains 
the face-to-face consultation with the patient (Papin-Lefebre et al.2017). 
Inconsistent or inadequate support from media: The participants also manifested the 
importance of information related to screening to encourage individuals to take the test 
regularly. They suggested that it is important to publicize the colorectal cancer screening 
program in the media. However, most studies highlight the lack of information and media 
interest in CRC screening, with more focus on the difficulty of discussing CRC screening with 
other individuals because it is considered a shameful subject (Beeker et al., 2000; Bridou et al., 
2013). 
Relaxation effect after a negative result in FOBT: Individuals who had once participated 
in the screening and had obtained a negative result in the FOBT indicated that they did not 
participate again because they believed that it was no longer necessary. However, this 
response is inconsistent with the available evidence because a high rate of consistent 
participation increased the program sensitivity of the FIT screening (Winawer et al, 1993; 
Nishihara et al, 2013). Therefore, the effectiveness of a FIT screening program is highly 
dependent on participation in multiple rounds. Consequently, once-in-a-lifetime participation is 
not sufficient to prevent colorectal cancer. This false relaxation does not occur in other types of 
cancer screening, such as breast or cervical cancer, in which women continue to participate 
after a negative screening test. 
Another study has shown that non-adherence is not caused by a difficulty related to performing 
the test, as the participants generally considered the test to be relatively simple to perform with 
no particular problems, at least compared with other similar types of medical procedures. This 
finding confirms the results of several authors who reported that this type of test is convenient 
and relatively simple to use (Bridou et al., 2013). Although most countries in Europe currently 
use the immunological test, the reasons for longitudinal adherence to colorectal cancer 
screening are common for both immunological and guaiac tests. 
An individual’s experience during the initial screen has been shown to influence her 
longitudinal adherence to screening (Bulliard et al., 2003; Maxwell et al., 1996). Several studies 
have shown that individuals who expressed dissatisfaction or negative views regarding their 
initial screen were more likely to not re-attend (Marshall, 1994; Orton et al., 1991; Peipins et al., 
2006). Thus, longitudinal adherence may be a good indicator of satisfaction because individuals 
who have been satisfied with the process are likely to re-attend during the subsequent round. 
Therefore, longitudinal adherence may be a proxy for measuring satisfaction in a feasible 
manner. Satisfaction with the cancer screening process should be an indicator that is evaluated 
on a regular basis. However, the determination of user satisfaction incurs significant costs. 
Consequently, ascertaining longitudinal adherence as an indicator of satisfaction could reduce 
costs and increase the feasibility of this indicator. In contrast and according to the current 
findings, non-adherence may result from not only non-satisfaction with the screening process 
but also a lack of knowledge, which was one factor identified in this study as a barrier to 
longitudinal adherence. 
This study has several limitations. We attempted to minimize several forms of bias by 
recruiting participants from different areas of the city and including both men and women of 
different ages and with varying degrees of experience with CRC screening. 
The qualitative nature of this study may limit the generalizability of our findings. However, 
qualitative research is concerned with generating insights that may be useful in different settings 
because the understanding that is generated is applicable to specific groups of individuals who 
share characteristics, engage in behaviors or live in circumstances relevant to the phenomenon 
investigated (Mays and Pope, 1995). This form of generalizability differs from that gained 
through statistical studies and was ensured by our sample strategy, which focused on reflecting 
the diversity within the population under study relevant to the research (including differences in 
prior screening behavior, socio-economic background, age, sex, ease of recruitment and initial 
FOBT results) rather than aspiring to recruit a representative sample.  
We will use the findings from our detailed analysis in this qualitative study to generate a 
framework to better understand facilitators and barriers that affect decision-making to participate 
in CRC screening. The results from these types of qualitative studies may be used to develop 
interventions to increase participation in colorectal cancer screening programs and specifically 
increase the longitudinal adherence.  
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Tables 
 
Table 1. Composition of the focus groups and demographic characteristics of 
participants. 
 
Focus 
groups 
Prior 
screening 
behavior  
Educational 
level 
Gender 
Total 
Male Female 
1 
Regular 
adherent 
Area 1 
 7 7 
2 6  6 
3 
Area 2 
 7 7 
4 7  7 
Total regular adherent participants 27 
5 
Irregular 
adherent 
Area 1 
 5 5 
6 7  7 
7 
Area 2 
 3 3 
8 3  3 
Total irregular adherent participants 18 
Total study participants 23 22 45 
 
 
 
Table 2. Sample focus group topic guide 
 
Introductory question 
 What was the first thing that came to mind when you received the letter of 
invitation to participate in the screening program? 
Main topics 
 Perceptions on form of invitation, reminders and information given 
 Perceptions on colorectal cancer, risk and early detection 
 Experiences/expectations of enrolment and participation 
 Experiences/expectations of taking the FOBT and receiving results 
 Experiences/expectations of colonoscopy and receiving results 
 Perceptions on continued/discontinued participation 
 Perceived benefits/disadvantages of taking part 
 
 
Table 3. Initial set of descriptive themes. 
 
Attitudes regarding the health care system 
GP’s or relatives’ involvement in CRC decision-making 
Improvements 
Attitudes regarding one’s own health 
Relatives or friends with CRC 
Competing health risks  
The value of screening (importance of early detection) 
CRC imaginary 
Regrets for having skipped at least one invitation to CRC screening 
Communication issues about CRC 
Implications of an initial negative result 
Fear 
Awareness of being adherent 
Awareness of being non-adherent 
Lack of information regarding the CRC screening process 
Laziness 
Completing the test 
Reputation of the screening program 
Table 4. Illustrative quotes from participants by themes and sub-themes. 
 
Themes and 
sub-themes 
  Illustrative quotes 
Theme 1: Common factors underpinning the screening experiences and decisions of regular and irregular adherent participants 
Perceived 
benefit of 
prevention 
1 "early diagnosis is very important (...) the patient must have enough time to understand what he has and what will happen" (Regular adherent, Area 1, Male) 
2 
"I would encourage all people who receive this, who have the opportunity, to do it. Because it is a... it is good. If you have problems, you will have it and it will 
be worse if they do not catch it in time. That's clear. No one is exempt from having anything." (Irregular adherent, Area 2, Male) 
3 
“I find this to be very good, because it is designed to prevent. And if I do not have anything, then it's great. And if I have something, and they detect it in time, 
then it is much better (...) you'll be a little afraid, it’s a hard pill to swallow, but sometimes it’s better to know as soon as possible... Well, sometimes, not 
always, but knowing the unpleasant news as soon as possible may make it pass better.” (Irregular adherent, Area 1, Female) 
Lack of 
comprehension 
4 
“I think it is an initiative that is well taken, but it is something long-term because I have not received anything for two years, then it is clear in two years many 
things could happen ... I find that the main problem (...) if this test is performed every six months it would be better than every year, an example, an example ... 
I find that every two years is too long, it is my opinion... " (Regular adherent, Area 2, Male) 
5 
“we have all been relaxed about it because none of us knew that the maximum period between analysis and analysis of the colon are two years, we did not 
know. And then, well, they have done it and that's it ... and it's not like that” (Irregular adherent, Area 1, Male) 
6 
"we have a greater chance of dying when we are older than when we are young, so surveillance should also be more stringent or more active when we become 
older than when we are young, so it is a request that I believe would be correct, that well, instead of cutting at 69, then after 69 years this disease, this damn 
cancer, does not rear its head, but what if? (...) well, I would like to be controlled at 69, 79 and 89 until ... until... " (Regular adherent, Area 1, Male) 
Lack of 
information 
about CRC in 
the media 
7 
"[we need] more information: what can cause or prevent colon cancer, I have not heard. And, as well as for other [cancers] they can almost guarantee that if 
you don’t smoke, don’t drink... [you can prevent it]. And still I have not heard any comments about the colon [cancer], I have not heard comments" (Regular 
adherent, Area 2, Male) 
8 
"Much more information about breast cancer than colon cancer is given on television, and Catalonia is, I think, a region that has more colon cancer [than 
breast cancer], and where is the information on television? (Irregular adherent, Area 1, Male) 
9 
"well I read the newspaper daily, and I listen to the media, and the truth is that there is not much talk about it [colorectal cancer]" (Irregular adherent, Area 1, 
Female) 
Satisfaction 
with the 
program 
10 
"when it comes to doing the [FOBT] test (...) I consider it [the FOBT test] a very comfortable thing. You do it in your house, at the moment" (Irregular adherent, 
Area 1, Male) 
11 
"The information is easy and can be understood very well. If I ever do not understand something, I ask my daughter, but it was not necessary because we 
understood it very well" (Irregular adherent, Area 2, Female) 
12 
"everyone should be grateful that today we have this [the screening program]. Because before we did not have it [available to us] (...) If this is something 
scientifically studied and works well (...) I see it as correct, so that whenever that... if it is increasing, it is something that the administration does well." 
(Irregular adherent, Area 2, Male) 
Theme 2: Common factors interpreted in opposed ways by regular and irregular adherent participants 
The role of fear 
in participants’ 
decision-
making 
13 
"the word cancer is something that... when someone talks about cancer, you do not want to hear about it, because today it's him and tomorrow it could be 
me... and I do not want anything to do with this disease.” (Regular adherent, Area 1, Male) 
14 
"It [CRC] imposes respect, because lately you do not hear about anything else, and of course the least you think... [is that you might have it]” (Regular 
adherent, Area 1, Female) 
15 
"I believe it [the reason why people does not participate] is what the lady says, that many people are afraid [of having cancer] and do not want [to know]" 
(Irregular adherent, Area 1, Female) 
16 
"there are many people who prefer to ignore things, until there is no remedy and then you have to face the problem and say, ok because there is no choice... 
but if I can avoid knowing... Then there will be a percentage of people who will also do it [to participate] out of fear. I think so" (Irregular adherent, Area 1, 
Female) 
Consulting a 
GP as part of 
the decision-
making 
process 
17 "I went to my GP [before making a decision] and they talked me through it [the letter] a bit" (Regular adherent, Area 1, Male) 
18 "I think it is important to consult with your GP [before you make a decision]" (Regular adherent, Area 2, Female) 
19 "Well, I did ask my doctor, and he told me: that's fine, if you want to do it, well. He did not give me any more explanations" (Irregular adherent, Area 2, Female) 
20 
"well, they do not tell you anything [about the program] in the health center. They have a lot of work and are... very serious. They do not tell you anything 
[about the program]" (Irregular adherent, Area 2, Female) 
Theme 3: differential factors across regular and irregular adherent participants 
Regular 
adherent 
participants: 
having a close 
person 
diagnosed with 
CRC 
21 “I have now a brother at the oncology department” (Regular adherent, Area 1, Female) 
22 
“all my relatives from my father's side died of cancer, most of them (...) not from my mother's side, but from my father's side yes. I think I've got a fifty 
percent” (Regular adherent, Area 1, Female) 
23 “there are quite a lot of colorectal cancers, I… various friends of mine have died” (Regular adherent, Area 2, Male) 
24 “my father died of colorectal cancer” (Regular adherent, Area 2, Male) 
Irregular 
adherent 
participants: 
prioritization 
issues and 
being relaxed 
about 
screening after 
a negative 
result 
25 
"you are getting on with your life, you are doing your things and can do it tomorrow, I will do it tomorrow. And in this case, well it has happened to me, to 
misplace items, because there is nothing that pushes you. As there isn't something, unless a personal concern pushes you to do it, then you do not do it." 
(Irregular adherent, Area 1, Male) 
26 
"It [to participate in the programe] seems very well to me, but the last time I received the letter I was preparing, we were to go away a few months with my 
son, and I thought, I will go when I get back, I will. And in the end, I didn't do it" (Irregular adherent, Area 2, Female) 
27 
"not having blood detected in the [first] test, we then assumed that there would be no cancer. One is then so happy already [that] in the second test you no 
longer value it in the same way as if you really had doubts (...) And then it seems that you relax about it, as if you said, ok it does not have great importance. 
But the truth is that it does." (Irregular adherent, Area 1, Male) 
28 
"They sent us the results of the [first] test, [it was] satisfactory, it was good. Everything was very good, everything very well. We were very well informed, there 
was no problem. Then the second year [the letter] arrived, right? And then [what happened is] what we all have said, one day after another [all you see] is how 
well you feel, and you say, for example, well, what am I going to have..." (Irregular adherent, Area 1, Male) 
 
 
